• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统抑制在 COVID-19 大流行期间的争议。

Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.

机构信息

Section of Nephrology, Department of Pediatrics, Wake Forest School of Medicine and Brenner Children's Hospital, Winston Salem, NC, USA.

Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, NC, USA.

出版信息

Nat Rev Nephrol. 2020 Jun;16(6):305-307. doi: 10.1038/s41581-020-0279-4.

DOI:10.1038/s41581-020-0279-4
PMID:32246101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118703/
Abstract

The current COVID-19 pandemic is associated with unprecedented morbidity and mortality. Early reports suggested an association between disease severity and hypertension but did not account for sources of confounding. However, the responsible virus — SARS-CoV-2 — gains entry to host cells via angiotensin-converting enzyme 2 (ACE2), highlighting the need to understand the relationship between the virus and the renin–angiotensin system (RAS) and how this might be affected by RAS inhibitors.

摘要

当前的 COVID-19 大流行与前所未有的发病率和死亡率有关。早期报告表明疾病严重程度与高血压之间存在关联,但并未考虑混杂因素的来源。然而,致病病毒——SARS-CoV-2 通过血管紧张素转换酶 2(ACE2)进入宿主细胞,这凸显了理解病毒与肾素-血管紧张素系统(RAS)之间的关系以及 RAS 抑制剂如何受到影响的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e2/7118703/c215fa78518b/41581_2020_279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e2/7118703/c215fa78518b/41581_2020_279_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1e2/7118703/c215fa78518b/41581_2020_279_Fig1_HTML.jpg

相似文献

1
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.肾素-血管紧张素系统抑制在 COVID-19 大流行期间的争议。
Nat Rev Nephrol. 2020 Jun;16(6):305-307. doi: 10.1038/s41581-020-0279-4.
2
Can beta-adrenergic blockers be used in the treatment of COVID-19?β-肾上腺素能阻滞剂可用于治疗新型冠状病毒肺炎吗?
Med Hypotheses. 2020 Sep;142:109809. doi: 10.1016/j.mehy.2020.109809. Epub 2020 May 5.
3
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.在对COVID-19中的RAS阻断进行快速判断之前的可靠科学依据。
Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716. doi: 10.2215/CJN.03530320. Epub 2020 Mar 27.
4
Drugs and the renin-angiotensin system in covid-19.新冠病毒肺炎中的药物与肾素-血管紧张素系统
BMJ. 2020 Apr 2;369:m1313. doi: 10.1136/bmj.m1313.
5
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.SARS-CoV-2 利用血管紧张素转换酶 2 进入细胞进行复制的机制概述:与肾素-血管紧张素系统相关的可能治疗选择。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325. doi: 10.1093/ehjcvp/pvaa053.
6
Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.血管紧张素转换酶2(ACE2)受体及血管紧张素转换酶抑制剂(ACEIs)/血管紧张素Ⅱ受体阻滞剂(ARBs)与新型冠状病毒肺炎(COVID-19)疾病严重程度的关联
Drug Discov Ther. 2020;14(4):161-170. doi: 10.5582/ddt.2020.03064.
7
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].[肾素-血管紧张素系统(RAS)与2019冠状病毒病——关于RAS阻滞剂的处方]
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.
8
COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?新型冠状病毒肺炎与肾素-血管紧张素系统抑制:血管紧张素转换酶 2(ACE2)的作用-争议有何科学依据?
J Intern Med. 2020 Oct;288(4):410-421. doi: 10.1111/joim.13101. Epub 2020 Jun 8.
9
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).螺内酯可能提供针对 SARS-CoV-2 的保护:靶向雄激素、血管紧张素转换酶 2(ACE2)和肾素-血管紧张素-醛固酮系统(RAAS)。
Med Hypotheses. 2020 Oct;143:110112. doi: 10.1016/j.mehy.2020.110112. Epub 2020 Jul 16.
10
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂对无高血压的新冠患者有益吗?
Pharmacol Res. 2020 Sep;159:104959. doi: 10.1016/j.phrs.2020.104959. Epub 2020 Jun 4.

引用本文的文献

1
Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis.长新冠中的持续性血管并发症:血管紧张素转换酶2失活、微血栓和均匀纤维化的作用。
Infect Dis Rep. 2024 Jun 27;16(4):561-571. doi: 10.3390/idr16040042.
2
The Epidemiology of COVID-19 Vaccine-Induced Myocarditis.新型冠状病毒肺炎疫苗诱导的心肌炎的流行病学
Adv Med. 2024 Apr 18;2024:4470326. doi: 10.1155/2024/4470326. eCollection 2024.
3
Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
3
Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.
肾素-血管紧张素系统/血管紧张素转换酶2机制在2型糖尿病中增强新型冠状病毒肺炎易感性的作用
World J Diabetes. 2024 Apr 15;15(4):606-622. doi: 10.4239/wjd.v15.i4.606.
4
COVID-19 susceptibility: potential of polymorphisms.新冠病毒易感性:多态性的可能性
Egypt J Med Hum Genet. 2020;21(1):54. doi: 10.1186/s43042-020-00099-9. Epub 2020 Sep 21.
5
The role of the brain renin-angiotensin system in Parkinson´s disease.脑肾素-血管紧张素系统在帕金森病中的作用。
Transl Neurodegener. 2024 Apr 15;13(1):22. doi: 10.1186/s40035-024-00410-3.
6
Cardiac Complications and COVID-19: A Review of Life-threatening Co-morbidities.心脏并发症与 COVID-19:危及生命的合并症综述。
Curr Cardiol Rev. 2024;20(3):1-12. doi: 10.2174/011573403X279782240206091322.
7
Intronic Variants of the Angiotensin-Converting Enzyme 2 Gene Modulate Plasma ACE2 Levels and Possibly Confer Protection against Severe COVID-19.血管紧张素转换酶 2 基因的内含子变异调节血浆 ACE2 水平,并可能为预防严重 COVID-19 提供保护。
Biomed Res Int. 2023 Oct 26;2023:5705076. doi: 10.1155/2023/5705076. eCollection 2023.
8
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword.管理 COVID-19 肺部炎症的免疫调节方法:一把双刃剑。
Immun Inflamm Dis. 2023 Sep;11(9):e1020. doi: 10.1002/iid3.1020.
9
and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury.一种中药配方NRICM101可减轻急性肺损伤的炎症和致病过程。
Medicina (Kaunas). 2023 Aug 26;59(9):1554. doi: 10.3390/medicina59091554.
10
Blood ACE2 Protein Level Correlates with COVID-19 Severity.血液 ACE2 蛋白水平与 COVID-19 严重程度相关。
Int J Mol Sci. 2023 Sep 11;24(18):13957. doi: 10.3390/ijms241813957.
胎儿编程与血管紧张素-(1-7)轴:实验与临床数据的综述。
Clin Sci (Lond). 2019 Jan 8;133(1):55-74. doi: 10.1042/CS20171550. Print 2019 Jan 15.
4
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.血浆血管紧张素转换酶 2 活性升高是阻塞性冠状动脉疾病患者主要不良心脏事件的独立预测因子。
PLoS One. 2018 Jun 13;13(6):e0198144. doi: 10.1371/journal.pone.0198144. eCollection 2018.
5
Classical Renin-Angiotensin system in kidney physiology.肾脏生理学中的经典肾素-血管紧张素系统。
Compr Physiol. 2014 Jul;4(3):1201-28. doi: 10.1002/cphy.c130040.
6
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.血管紧张素转换酶2在肾血管系统中的定位:使用替米沙坦通过1型血管紧张素II受体阻断进行放大。
Am J Physiol Renal Physiol. 2009 Feb;296(2):F398-405. doi: 10.1152/ajprenal.90488.2008. Epub 2008 Nov 12.
7
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.血管紧张素转换酶2(ACE2)在严重急性呼吸综合征冠状病毒诱导的肺损伤中的关键作用。
Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.
8
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.血管紧张素转换酶抑制和血管紧张素II受体阻滞剂对心脏血管紧张素转换酶2的影响。
Circulation. 2005 May 24;111(20):2605-10. doi: 10.1161/CIRCULATIONAHA.104.510461. Epub 2005 May 16.
9
Myocardial infarction increases ACE2 expression in rat and humans.心肌梗死会增加大鼠和人类体内血管紧张素转换酶2(ACE2)的表达。
Eur Heart J. 2005 Feb;26(4):369-75; discussion 322-4. doi: 10.1093/eurheartj/ehi114. Epub 2005 Jan 25.